Market Exclusive

Analyst Downgrades – Amedisys (NASDAQ:AMED) Stock Gets Downgraded By Mizuho from Buy to Neutral

Analyst Ratings For Amedisys (NASDAQ:AMED)

Today, Amedisys (NASDAQ:AMED) stock was downgraded by Mizuho from Buy to Neutral.

There are 4 hold ratings, 4 buy ratings on the stock.

The current consensus rating on Amedisys (NASDAQ:AMED) is Buy (Score: 2.50) with a consensus target price of $58.29 per share, a potential 1.89% downside.

Some recent analyst ratings include

Recent Insider Trading Activity For Amedisys (NASDAQ:AMED)
Amedisys (NASDAQ:AMED) has insider ownership of 2.80% and institutional ownership of 99.10%.

Recent Trading Activity for Amedisys (NASDAQ:AMED)
Shares of Amedisys closed the previous trading session at 59.41 up +0.61 1.04% with 241,864 shares trading hands.

Exit mobile version